Product NDC: | 67386-411 |
Proprietary Name: | Elspar |
Non Proprietary Name: | asparaginase |
Active Ingredient(s): | 10000 [iU]/1 & nbsp; asparaginase |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67386-411 |
Labeler Name: | Lundbeck LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA101063 |
Marketing Category: | BLA |
Start Marketing Date: | 19780110 |
Package NDC: | 67386-411-51 |
Package Description: | 1 VIAL in 1 CARTON (67386-411-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 67386-411-51 |
Proprietary Name | Elspar |
Package Description | 1 VIAL in 1 CARTON (67386-411-51) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 67386-411 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | asparaginase |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19780110 |
Marketing Category Name | BLA |
Labeler Name | Lundbeck LLC |
Substance Name | ASPARAGINASE |
Strength Number | 10000 |
Strength Unit | [iU]/1 |
Pharmaceutical Classes | Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] |